Loparex is the leading global manufacturer of release liners, and the only manufacturer with production facilities across North America, Europe and Asia Pacific. Loparex has a strong reputation for product innovation and is recognized as a technology leader in its industry. Release liners are used across a wide array of different applications and industries such as graphic arts, tapes, composites, medical, electronics, automotive, construction, labels and hygiene. The release liner markets are attractive with above GDP growth and constantly evolving new application areas. The company is managed by a highly experienced management team, led by the CEO Michael Apperson.
The investment will be made by ICG Europe Fund V, and Loparex will be the final investment of the fund. The transaction is subject to customary competition clearances.
Benoit Durteste, Managing Director and Head of European Investments at ICG, commented on the transaction:
Loparex is a leading company in its specialist area of manufacturing with an excellent management team, a strong strategy and business model. ICG is delighted to be investing in this company and looks forward to being part of the next phase of Loparex’s development. Loparex is well positioned to maintain and grow its market leadership. We see great opportunities ahead both through organic growth and market consolidation.
Subscribe to our newsletters
Sign up for Regulatory News updates: click here
